|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net Cash Provided by (Used in) Operating Activities | |||||
| Net loss | |||||
| Cash flows from operating activities: | |||||
| Goodwill and asset impairment | |||||
| Depreciation and amortization | |||||
| Stock-based compensation expense | |||||
| Non-cash interest expense | |||||
| Gain on investment in ESAB Corporation | |||||
| Gain on cost basis investments | |||||
| Fair value gain on contingency shares | |||||
| Unrealized loss (gain) on currency hedges | |||||
| Debt extinguishment charges | |||||
| Deferred income tax expense (benefit) | |||||
| (Gain) loss on sale of property, plant and equipment | |||||
| Pension settlement gain | |||||
| Changes in operating assets and liabilities: | |||||
| Trade receivables, net | |||||
| Inventories, net | |||||
| Accounts payable | |||||
| Other operating assets and liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of property, plant and equipment and intangibles | |||||
| Proceeds from sale of property, plant and equipment | |||||
| Payments for acquisitions, net of cash received, and investments | |||||
| Proceeds from sale of business, net | |||||
| Cash received (paid) for settlement of derivative | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from borrowings on term credit facility | |||||
| Repayments of borrowings under term credit facility | |||||
| Proceeds from borrowings on revolving credit facilities and other | |||||
| Repayments of borrowings on revolving credit facilities and other | |||||
| Repayments of borrowings on senior notes | |||||
| Proceeds from borrowings on senior unsecured convertible notes | |||||
| Distribution from ESAB Corporation, net | |||||
| Payment of debt issuance costs | |||||
| Proceeds from issuance of common stock, net | |||||
| Payment of debt extinguishment costs | |||||
| Payment of capped call transactions | |||||
| Payments of tax withholding for stock-based awards | |||||
| Deferred consideration payments and other | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of foreign exchange rates on Cash and cash equivalents | |||||
| Increase (decrease) in Cash and cash equivalents and restricted cash | |||||
| Cash and cash equivalents and restricted cash, beginning of period | |||||
| Cash and cash equivalents and restricted cash, end of period | |||||
| Supplemental disclosures: | |||||
| Interest payments | |||||
| Income tax payments, net | |||||
| Common stock issued for acquisition, net of issuance costs | |||||
| ESAB Corporation shares exchanged for debt, net of fees | |||||
Loading...